Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy
Yi Bao(Michigan Center for Translational Pathology), Arul M. Chinnaiyan(University of Michigan), Ilona Kryczek(University of Michigan), Sara Grove(University of Michigan), Jiali Yu(University of Michigan), Yu‐Sun Chang(Chang Gung University of Science and Technology), Michael D. Green(University of Michigan), Xuhong Cao(Howard Hughes Medical Institute), Mahnoor Gondal(University of Michigan), Marcin Cieślik(University of Michigan), Rahul Mannan(University of Michigan), Fengyun Su(University of Michigan), Tongchen He(Central South University), Weiping Zou(University of Michigan), Yuping Zhang(University of Michigan), Rui Wang(University of Michigan), Yang Zheng(Harbin Medical University), Caleb Cheng(University of Michigan), Jae Eun Choi(University of Michigan), Gabriel Cruz(University of Michigan), Yuanyuan Qiao(University of Michigan)
Cited by 31
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k